Jiu-Yao Wang Selected Research

Jiu-Yao Wang Research Topics

Disease

33	Asthma (Bronchial Asthma) 05/2021 - 01/2002
19	Inflammation (Inflammations) 01/2021 - 01/2003
11	Hypersensitivity (Allergy) 11/2021 - 01/2006
6	Neoplasms (Cancer) 01/2020 - 08/2003
6	Respiratory Hypersensitivity 01/2019 - 07/2006
5	Pneumonia (Pneumonitis) 01/2021 - 05/2008
4	Allergic Rhinitis 01/2020 - 07/2011
3	Infections 01/2021 - 01/2017
3	Airway Remodeling 03/2013 - 01/2006
2	Respiratory Sounds (Crackle) 05/2021 - 08/2008
2	COVID-19 01/2021 - 01/2021
2	Chronic Renal Insufficiency 01/2021 - 06/2015
2	Atopic Dermatitis (Atopic Eczema) 03/2020 - 08/2013
2	Lung Diseases (Lung Disease) 03/2013 - 04/2011
2	Hyperplasia 02/2011 - 05/2008
1	Disease Susceptibility (Diathesis) 11/2021
1	Chronic Urticaria 04/2021
1	Sepsis (Septicemia) 01/2021
1	Enterovirus Infections 01/2021
1	Hemorrhage 01/2021
1	Glaucoma 01/2021
1	Cicatrix (Scar) 01/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Drug Hypersensitivity (Drug Allergy) 01/2020
1	Insulin Resistance 01/2020
1	Anaphylaxis (Anaphylactic Shock) 01/2018
1	Tuberculosis (Tuberculoses) 01/2018
1	Wounds and Injuries (Trauma) 01/2017
1	Overweight 05/2016
1	Obesity 05/2016
1	Iron Overload 01/2016
1	Diabetes Mellitus 06/2015
1	Mental Disorders (Mental Disorder) 06/2015
1	Hypertension (High Blood Pressure) 06/2015
1	Coronary Disease (Coronary Heart Disease) 06/2015
1	Hyperlipidemias (Hyperlipidemia) 06/2015
1	Central Serous Chorioretinopathy 06/2015
1	Peptic Ulcer (Peptic Ulcers) 06/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2015

Drug/Important Bio-Agent (IBA)

24	AllergensIBA 01/2021 - 01/2002
8	Immunoglobulin E (IgE)IBA 11/2021 - 01/2002
7	CytokinesIBA 01/2019 - 07/2006
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2007
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 07/2012
3	Thymic Stromal LymphopoietinIBA 01/2021 - 05/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2015
3	Biological ProductsIBA 01/2020 - 05/2008
3	Pharmaceutical PreparationsIBA 01/2020 - 08/2013
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2018 - 01/2007
3	Nerve Growth Factor (NGF)IBA 10/2017 - 02/2011
2	phthalic acid (phthalate)IBA 11/2021 - 01/2021
2	Air Pollutants (Pollutants, Air)IBA 05/2021 - 01/2020
2	Immunoglobulin A (IgA)IBA 01/2021 - 01/2014
2	Environmental Pollutants (Pollutants, Environmental)IBA 01/2021 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2003
2	ChitosanIBA 10/2017 - 05/2008
2	Bronchodilator Agents (Bronchodilators)IBA 02/2015 - 08/2008
2	anti-IgE antibodiesIBA 05/2014 - 10/2013
2	Therapeutic UsesIBA 09/2013 - 07/2006
2	sho-seiryu-toIBA 09/2013 - 07/2012
2	Interleukin-17 (Interleukin 17)IBA 07/2012 - 04/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2011 - 08/2003
1	PlasticizersIBA 11/2021
1	Adenine FDA LinkGeneric 01/2021
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2021
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 03/2020
1	Contrast MediaIBA 01/2020
1	beta Lactam AntibioticsIBA 01/2020
1	Allopurinol (Remid)FDA LinkGeneric 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	AntibodiesIBA 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Penicillins (Penicillin)FDA Link 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	HLA-B Antigens (HLA-B)IBA 01/2020
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2020
1	OvalbuminIBA 01/2019
1	Dichlorodiphenyldichloroethane (DDD)IBA 09/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2018
1	insulin receptor-related receptor (IRR)IBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2018
1	Methacholine Chloride (Methacholine)FDA Link 01/2018
1	Arginine (L-Arginine)FDA Link 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	InterleukinsIBA 01/2016
1	IronIBA 01/2016
1	Photosensitizing Agents (Photosensitizers)IBA 08/2015
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 08/2015
1	GoldIBA 08/2015

Therapy/Procedure

9	Therapeutics 04/2021 - 08/2006
2	Subcutaneous Injections 03/2020 - 08/2006
1	Percutaneous Coronary Intervention 01/2020
1	Immunotherapy 11/2018
1	Critical Care (Surgical Intensive Care) 01/2018
1	Immunomodulation 01/2018
1	Ambulatory Care (Outpatient Care) 05/2016
1	Lasers (Laser) 08/2015